Lake Street Capital upgraded shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) to a strong-buy rating in a report issued on Tuesday, Zacks.com reports. A number of other brokerages also recently issued reports on RKDA. StockNews.com started coverage on shares of Arcadia Biosciences in a research report on Wednesday. They set a sell rating on […]